Literature DB >> 3264876

Serum osteocalcin in primary hyperparathyroidism: short-term effect of surgery.

S Minisola1, L Scarnecchia, A Scarda, F Bigi, S Tabolli, C Valtorta, G Mazzuoli.   

Abstract

This study has been carried out in order to evaluate both serum osteocalcin levels in primary hyperparathyroidism and their changes following surgery. Twenty-one consecutive patients were studied (12 females and 9 males, aged 46 +/- 17 years). Preoperatively, a better correlation was found between serum osteocalcin and serum alkaline phosphatase activity (r = 0.79, p less than 0.001) than between serum osteocalcin and the 24-hour urinary hydroxyproline/creatine ratio (r = 0.55, p less than 0.05). Following the surgical removal of hyperfunctioning parathyroid tissue, a modest but significant decrease was observed in the serum levels of osteocalcin; this reached a nadir during the 1st or 2nd day after the removal of the adenoma. The mean levels then tended to rise, so that the values measured on the 7th day after parathyroidectomy (12.4 +/- 2.5 ng/ml) were not significantly different in respect to basal values (13.6 +/- 2.7 ng/ml). A parallel pattern was also noted as concerns the serum alkaline phosphatase activity. On the contrary, mean values of serum immunoreactive parathyroid hormone (243 +/- 78 vs. 58 +/- 11 pmol/l; p less than 0.02) and serum calcium (12.4 +/- 0.5 vs. 9.2 +/- 0.3 mg/dl; p less than 0.01) were significantly reduced and mean values of serum phosphorus (2.4 +/- 0.2 vs. 3.1 +/- 0.2 mg/dl; p less than 0.001) significantly higher in comparison to basal values.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264876

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  10 in total

1.  Sex does not influence serum osteocalcin levels in standardbred horses of different ages.

Authors:  O M Lepage; M Marcoux; A Tremblay; G Dumas
Journal:  Can J Vet Res       Date:  1992-10       Impact factor: 1.310

2.  Serum osteocalcin levels in primary hyperparathyroidism.

Authors:  P Pietschmann; B Niederle; A Anvari; W Woloszczuk
Journal:  Klin Wochenschr       Date:  1991-05-24

3.  Clinical value of the measurement of bone remodelling markers in primary hyperparathyroidism.

Authors:  S Minisola; L Scarnecchia; V Carnevale; F Bigi; E Romagnoli; M T Pacitti; R Rosso; G F Mazzuoli
Journal:  J Endocrinol Invest       Date:  1989-09       Impact factor: 4.256

4.  The usefulness of high pre-operative levels of serum type I collagen bone markers for the prediction of changes in bone mineral density after parathyroidectomy.

Authors:  S Alonso; E Ferrero; M Donat; G Martínez; C Vargas; M Hidalgo; E Moreno
Journal:  J Endocrinol Invest       Date:  2011-09-23       Impact factor: 4.256

5.  Emerging data on cardiovascular risk in primary hyperparathyroidism.

Authors:  Jessica Pepe; Sara Piemonte; Cristiana Cipriani; Mirella Cilli; Salvatore Minisola
Journal:  Endocrine       Date:  2014-09-10       Impact factor: 3.633

6.  Hypovitaminosis D in primary hyperparathyroidism: to treat or not to treat? That is the question.

Authors:  Salvatore Minisola; Elisabetta Romagnoli; Alfredo Scillitani; Sudhakar D Rao
Journal:  J Endocrinol Invest       Date:  2014-03-20       Impact factor: 4.256

7.  Serum osteocalcin in metabolic bone diseases: what is its real significance?

Authors:  S Minisola; V Carnevale; M T Pacitti; E Romagnoli; L Scarnecchia; R Rosso; G Minisola; G F Mazzuoli
Journal:  J Endocrinol Invest       Date:  1993-04       Impact factor: 4.256

8.  Potential utility of high preoperative levels of serum type I collagen markers in postmenopausal women with primary hyperparathyroidism with respect to their short-term variations after parathyroidectomy.

Authors:  Philippe Boudou; Fidaa Ibrahim; Catherine Cormier; Emile Sarfati; Jean-Claude Souberbielle
Journal:  J Bone Miner Metab       Date:  2009-01-27       Impact factor: 2.626

9.  Decrease of serum calcium concentration and lost influence of calcium on parathyroid hormone release in a patient with primary hyperparathyroidism after treatment with diphosphonates.

Authors:  H Kotzmann; P Bernecker; T Svoboda; B Niederle; A Luger
Journal:  Calcif Tissue Int       Date:  1993-11       Impact factor: 4.333

10.  Conventional and new diagnostic applications of a two-site immunochemiluminometric assay for parathyroid hormone.

Authors:  S Minisola; L Scarnecchia; E Romagnoli; V Carnevale; M T Pacitti; A Scarda; R Rosso; G F Mazzuoli
Journal:  J Endocrinol Invest       Date:  1992 Jul-Aug       Impact factor: 4.256

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.